Literature DB >> 11414365

gC1q-R/p33, a member of a new class of multifunctional and multicompartmental cellular proteins, is involved in inflammation and infection.

B Ghebrehiwet1, B L Lim, R Kumar, X Feng, E I Peerschke.   

Abstract

Human gC1q-R (p33, p32, C1qBP, TAP) is a ubiquitously expressed, multiligand-binding, multicompartmental cellular protein involved in various ligand-mediated cellular responses. Although expressed on the surface of cells, an intriguing feature of the membrane-associated form of gC1q-R is that its translated amino acid sequence does not predict the presence of either a sequence motif compatible with a transmembrane segment or a consensus site for a glycosylphosphatidylinositol anchor. Moreover, the N-terminal sequence of the pre-pro-protein gC1q-R contains a motif that targets the molecule to the mitochondria and as such was deemed unlikely to be expressed on the surface. However, several lines of experimental evidence clearly show that gC1q-R is present in all compartments of the cell, including the extracellular cell surface. First, surface labeling of B lymphocytes with the membrane-impermeable reagent sulfosuccinimidyl 6-(biotinamido)hexanoate shows specific biotin incorporation into the surface-expressed but not the intracellular form of gC1q-R. Second, FACS and confocal laser scanning microscopic analyses using anti-gC1q-R IgG mAb 60.11 or 74.5.2, and the fluorophore Alexa 488-conjugated F(ab')2 goat anti-mouse IgG as a probe, demonstrated specific staining of Raji cells (>95% viable). Three-dimensional analyses of the same cells by confocal microscopy showed staining distribution that was consistent with surface expression. Third, endothelial gC1q-R, which is associated with the urokinase plasminogen activator receptor, and cytokeratin 1 bind 125I-high molecular weight kininogen in a specific manner, and the binding is inhibited dose-dependently by mAb 74.5.2 recognizing gC1q-R residues 204-218. Fourth, native gC1q-R purified from Raji cell membranes but not intracellular gC1q-R is glycosylated, as evidenced by a positive periodic acid Schiff stain as well as sensitivity to digestion with endoglycosidase H and F. Finally, cross-linking experiments using C1q as a ligand indicate that both cC1q-R and gC1q-R are co-immunoprecipitated with anti-C1q. Taken together, the evidence accumulated to date supports the concept that in addition to its intracellular localization, gC1q-R is expressed on the cell surface and can serve as a binding site for plasma and microbial proteins, but also challenges the existing paradigm that mitochondrial proteins never leave their designated compartment. It is therefore proposed that gC1q-R belongs to a growing list of a class of proteins initially targeted to the mitochondria but then exported to different compartments of the cell through specific mechanisms which have yet to be identified. The designation 'multifunctional and multicompartmental cellular proteins' is proposed for this class of proteins.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11414365     DOI: 10.1034/j.1600-065x.2001.1800106.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  57 in total

1.  A proteomic approach to identification of plutonium-binding proteins in mammalian cells.

Authors:  Baikuntha P Aryal; Tatjana Paunesku; Gayle E Woloschak; Chuan He; Mark P Jensen
Journal:  J Proteomics       Date:  2011-12-03       Impact factor: 4.044

Review 2.  Structural and functional anatomy of the globular domain of complement protein C1q.

Authors:  Uday Kishore; Rohit Ghai; Trevor J Greenhough; Annette K Shrive; Domenico M Bonifati; Mihaela G Gadjeva; Patrick Waters; Mihaela S Kojouharova; Trinad Chakraborty; Alok Agrawal
Journal:  Immunol Lett       Date:  2004-09       Impact factor: 3.685

3.  Subcellular localization of fumarase in mammalian cells and tissues.

Authors:  Timothy Bowes; Bhag Singh; Radhey S Gupta
Journal:  Histochem Cell Biol       Date:  2006-11-17       Impact factor: 4.304

4.  Localization of mitochondrial DNA encoded cytochrome c oxidase subunits I and II in rat pancreatic zymogen granules and pituitary growth hormone granules.

Authors:  Skanda K Sadacharan; Bhag Singh; Timothy Bowes; Radhey S Gupta
Journal:  Histochem Cell Biol       Date:  2005-11-03       Impact factor: 4.304

5.  Protruding disordered loop of gC1qR is specifically exposed and related to antiapoptotic property in germ cell lineage.

Authors:  Sohei Kitazawa; Atsushi Takenaka; Takeshi Kondo; Akira Mizoguchi; Riko Kitazawa
Journal:  Histochem Cell Biol       Date:  2006-07-27       Impact factor: 4.304

6.  SOCS1 and SOCS3 are targeted by hepatitis C virus core/gC1qR ligation to inhibit T-cell function.

Authors:  Zhi Qiang Yao; Stephen N Waggoner; Michael W Cruise; Caroline Hall; Xuefang Xie; David W Oldach; Young S Hahn
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

7.  Cell-surface receptor for complement component C1q (gC1qR) is a key regulator for lamellipodia formation and cancer metastasis.

Authors:  Ki-Bum Kim; Jae-Sung Yi; Nga Nguyen; Joo-Hyung Lee; Young-Chan Kwon; Byung-Yoon Ahn; Hana Cho; Yoon Ki Kim; Hee-Jung Yoo; Jae-Seon Lee; Young-Gyu Ko
Journal:  J Biol Chem       Date:  2011-05-02       Impact factor: 5.157

8.  Interactions between RNA-binding proteins and P32 homologues in trypanosomes and human cells.

Authors:  Juan Manuel Polledo; Gabriela Cervini; María Albertina Romaniuk; Alejandro Cassola
Journal:  Curr Genet       Date:  2015-09-18       Impact factor: 3.886

9.  Targeting and crossing of the human maternofetal barrier by Listeria monocytogenes: role of internalin interaction with trophoblast E-cadherin.

Authors:  Marc Lecuit; D Michael Nelson; Steve D Smith; Huot Khun; Michel Huerre; Marie-Cécile Vacher-Lavenu; Jeffrey I Gordon; Pascale Cossart
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-08       Impact factor: 11.205

10.  HIV gp41 engages gC1qR on CD4+ T cells to induce the expression of an NK ligand through the PIP3/H2O2 pathway.

Authors:  Hugues Fausther-Bovendo; Vincent Vieillard; Sandrine Sagan; Georges Bismuth; Patrice Debré
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.